Viatris, Inc. (VTRS)
18.00
-0.48
(-2.60%)
USD |
NASDAQ |
Oct 23, 16:00
18.12
+0.12
(+0.67%)
After-Hours: 20:00
Viatris Price to Book Value : 1.458 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.458 |
| October 22, 2026 | 1.497 |
| October 21, 2026 | 1.495 |
| October 20, 2026 | 1.511 |
| October 19, 2026 | 1.479 |
| October 16, 2026 | 1.511 |
| October 15, 2026 | 1.476 |
| October 14, 2026 | 1.413 |
| October 13, 2026 | 1.397 |
| October 12, 2026 | 1.421 |
| October 09, 2026 | 1.429 |
| October 08, 2026 | 1.413 |
| October 07, 2026 | 1.417 |
| October 06, 2026 | 1.421 |
| October 05, 2026 | 1.427 |
| October 02, 2026 | 1.426 |
| October 01, 2026 | 1.414 |
| September 30, 2026 | 1.436 |
| September 29, 2026 | 1.468 |
| September 28, 2026 | 1.480 |
| September 25, 2026 | 1.444 |
| September 24, 2026 | 1.411 |
| September 23, 2026 | 1.387 |
| September 22, 2026 | 1.392 |
| September 21, 2026 | 1.385 |
| Date | Value |
|---|---|
| September 18, 2026 | 1.373 |
| September 17, 2026 | 1.388 |
| September 16, 2026 | 1.379 |
| September 15, 2026 | 1.349 |
| September 14, 2026 | 1.350 |
| September 11, 2026 | 1.338 |
| September 10, 2026 | 1.327 |
| September 09, 2026 | 1.337 |
| September 08, 2026 | 1.346 |
| September 04, 2026 | 1.368 |
| September 03, 2026 | 1.372 |
| September 02, 2026 | 1.384 |
| September 01, 2026 | 1.347 |
| August 31, 2026 | 1.338 |
| August 28, 2026 | 1.324 |
| August 27, 2026 | 1.368 |
| August 26, 2026 | 1.365 |
| August 25, 2026 | 1.354 |
| August 24, 2026 | 1.340 |
| August 21, 2026 | 1.322 |
| August 20, 2026 | 1.306 |
| August 19, 2026 | 1.316 |
| August 18, 2026 | 1.310 |
| August 17, 2026 | 1.315 |
| August 14, 2026 | 1.315 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pacira Biosciences, Inc. | 2.158 |
| Eli Lilly & Co. | 35.39 |
| Merck & Co., Inc. | 8.552 |
| Pfizer Inc. | 2.009 |
| Harrow, Inc. | 70.14 |
Price to Book Value Related Metrics
| PS Ratio | 1.420 |
| Price to Free Cash Flow | 11.60 |
| Price | 18.00 |
| Earnings Yield | -1.98% |
| Market Cap | 20.79B |
| Operating PE Ratio | 14.66 |
| Normalized PE Ratio | 35.66 |